22nd Mar 2007 07:00
Beximco Pharmaceuticals Ltd22 March 2007 BEXIMCO PHARMACEUTICALS LTD. 22 March 2007 Beximco Pharmaceuticals Commences Exports to Central America Beximco Pharmaceuticals Limited ("BPL" or the "Company"), the leading drugmanufacturer in Bangladesh, announces that it has commenced exporting drugs intoBelize, Central America. The first consignment of medicines from BPL included twenty five productscovering a wide range of therapeutic categories, including antihistamine,antihypertensive, antibacterial, lipid lowering, respiratory, antiulcerant andpain relievers. The Company already exports pharmaceuticals into a number of countries in EastAfrica and South East Asia and is now seeking to build its presence in Centraland South America. Mr. Nazmul Hassan, CEO of Beximco Pharma said: "Entering Central and South America is a strategic objective for BPL in its planto build up exports to highly regulated countries and we are pleased to beexporting such a wide range of medicines to Belize. This is a major achievementfor BPL and I expect that this will facilitate the development of new markets inother Central and South American countries." For further enquiries please contact: Beximco Pharma Tel: +880 2 861 9151, ext.2080 Nazmul Hassan, CEO Libertas Capital Tel: +44 (0)20 7569 9650 Aamir Quraishi/Andrew Hardy Financial Dynamics Tel: +44 (0)20 7269 7169 John Gilbert About Beximco Pharmaceuticals Limited Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sellsgeneric pharmaceutical formulation products, active pharmaceutical ingredientsand intravenous fluids. The Company also manufactures and markets its ownbranded generics for almost all diseases. The Company also undertakes contractmanufacturing for multinational pharmaceutical companies. The Company operatesfrom a 20 acre site in Dhaka and currently employs over 2,300 staff. The Company's products are sold to retail outlets, medical institutions andother pharmaceutical manufacturers in Bangladesh, in regional markets such asPakistan, Nepal, Bhutan and Myanmar and in other markets overseas, principallyin East Africa and South East Asia, including Singapore. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Beximco Pharma